Seoulin Bioscience Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 18, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	44,706	57,463	61,462	78,767	97,546	174,747
Market Cap Growth	-33.39%	-6.51%	-21.97%	-19.25%	-44.18%	62.58%
Enterprise Value	23,596	37,707	39,202	46,863	48,995	136,075
Last Close Price	4950.00	6510.00	6845.95	8533.50	10440.22	18480.13
PE Ratio	151.07	78.50	21.09	-	9.60	11.21
PS Ratio	0.57	0.75	0.82	0.88	0.93	2.17
PB Ratio	0.52	0.67	0.71	0.92	1.10	2.28
P/TBV Ratio	0.54	0.69	0.74	0.96	1.17	2.36
P/FCF Ratio	45.84	13.16	-	-	-	21.89
P/OCF Ratio	32.93	12.07	-	84.64	-	19.60
EV/Sales Ratio	0.30	0.49	0.52	0.52	0.47	1.69
EV/EBITDA Ratio	12.17	20.33	16.92	12.39	4.80	14.51
EV/EBIT Ratio	29.85	54.52	41.15	18.79	5.33	18.26
EV/FCF Ratio	24.20	8.64	-	-	-	17.04
Debt / Equity Ratio	0.14	0.14	0.04	0.08	0.20	0.21
Debt / EBITDA Ratio	6.20	6.24	1.59	1.78	1.74	1.68
Debt / FCF Ratio	12.19	2.65	-	-	-	1.97
Net Debt / Equity Ratio	-0.27	-0.27	-0.23	-0.34	-0.42	-0.78
Net Debt / EBITDA Ratio	-11.97	-12.47	-8.56	-7.59	-3.67	-6.35
Net Debt / FCF Ratio	-23.52	-5.30	4.26	1920.12	7.78	-7.46
Asset Turnover	0.71	0.70	0.70	0.72	0.77	0.75
Inventory Turnover	2.53	2.35	2.35	3.57	5.15	4.63
Quick Ratio	1.32	1.37	2.30	1.77	1.35	1.44
Current Ratio	2.23	2.28	4.39	2.60	1.88	1.77
Return on Equity (ROE)	0.51%	0.66%	3.65%	-2.67%	12.78%	23.03%
Return on Assets (ROA)	0.43%	0.39%	0.55%	1.25%	4.23%	4.34%
Return on Invested Capital (ROIC)	0.82%	0.69%	1.36%	4.63%	20.31%	19.66%
Return on Capital Employed (ROCE)	0.90%	0.80%	1.10%	2.90%	10.30%	9.70%
Earnings Yield	1.16%	1.27%	4.74%	-0.15%	10.41%	8.92%
FCF Yield	2.18%	7.60%	-7.58%	-0.02%	-4.94%	4.57%
Payout Ratio	162.80%	115.25%	28.70%	-	7.86%	4.93%
Buyback Yield / Dilution	-11.59%	-10.81%	2.96%	19.46%	-23.72%	0.07%